Eleni Papakonstantinou
- Cigarette smoke alters hyaluronic acid homeostasis in primary human lung fibroblastsBy Eleni Papakonstantinou, Ioannis Klagas, Nicola Miglino, George Karakiulakis, Michael Tamm and Michael RothEleni Papakonstantinou1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceNicola Miglino2Pulmonary Cell Research and Pneumology, Universtity Hospital Basel, Basel, SwitzerlandGeorge Karakiulakis1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Tamm2Pulmonary Cell Research and Pneumology, Universtity Hospital Basel, Basel, SwitzerlandMichael Roth2Pulmonary Cell Research and Pneumology, Universtity Hospital Basel, Basel, Switzerland
- Anti-fibrotic effects of nintedanib (BIBF 1120) in primary human lung fibroblasts derived from idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, George Karakiulakis, Michael Tamm, Didier Lardinois and Michael RothKatrin Hostettler1Department of Biomedicine, University Hospital, Basel, BS, SwitzerlandEleni Papakonstantinou2Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceIoannis Klagas2Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceGeorge Karakiulakis2Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceMichael Tamm3Clinic of Respiratory Medicine, University Hospital, Basel, BS, SwitzerlandDidier Lardinois4Division of Thoracic Surgery, University Hospital, Basel, BS, SwitzerlandMichael Roth1Department of Biomedicine, University Hospital, Basel, BS, Switzerland
- MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPDBy Eleni Papakonstantinou, Michael Tamm, Michael Roth and Daiana StolzEleni Papakonstantinou1Pharmacology, School of Medicine, Aristotle University, Thessaloniki, GreeceMichael Tamm2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandMichael Roth2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, SwitzerlandDaiana Stolz2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbationBy Eleni Papakonstantinou, Michael Roth, George Karakiulakis, Spasenija Savic, Michael Tamm and Daiana StolzEleni Papakonstantinou1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Roth2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandGeorge Karakiulakis1Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceSpasenija Savic3Department of Pathology, University Hospital Basel, Basel, SwitzerlandMichael Tamm2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz2Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Aclidinium bromide reduces extracellular matrix deposition by COPD-derived mesenchymal cellsBy Christopher Lambers, Ying Qi, Eleni Papakonstantinou, Elisabeth Schuller, Michael Roth and Lutz-Hening BlockChristopher Lambers1Respiratory Medicine, Medizinische University Wien, Wien, AustriaYing Qi2Department Biomedicine & Pneumology, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou3Pharmacology, School of Medicine, Thessaloniki, GreeceElisabeth Schuller4Medical Affairs, Almirall GmbH Austria and Almirall AG, Austria, SwitzerlandMichael Roth2Department Biomedicine & Pneumology, University Hospital Basel, Basel, SwitzerlandLutz-Hening Block1Respiratory Medicine, Medizinische University Wien, Wien, Austria
- Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPDBy Michael Roth, Daiana Stolz, Eleni Papakonstantinou, Ioannis Bonovolias, George Karakiulakis and Michael TammMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandIoannis Bonovolias2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, SwitzerlandGeorge Karakiulakis2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BALBy Eleni Papakonstantinou, Ioannis Klagas, Spyros Batzios, Michael Roth, Michael Tamm and Daiana StolzEleni Papakonstantinou1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandIoannis Klagas2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, GreeceSpyros Batzios2Department of Pharmacology, School of Medicine, A.U.T.H, Thessaloniki, GreeceMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
- Nintedanib (BIBF 1120) prevents TGF-Ī²-induced pro-fibrotic effects in primary human lung myofibroblasts derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Jun Zhong, George Karakiulakis, Didier Lardinois, Michael Tamm and Michael RothKatrin Hostettler1Department of BioMedicine, University Hospital Basel, Basel, Switzerland2Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou3Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceJun Zhong1Department of BioMedicine, University Hospital Basel, Basel, SwitzerlandGeorge Karakiulakis3Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceDidier Lardinois4Division of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of BioMedicine, University Hospital Basel, Basel, Switzerland2Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of BioMedicine, University Hospital Basel, Basel, Switzerland
- Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatmentBy Eleni Papakonstantinou, Ioannis Klagas, George Karakiulakis, Spasenija Savic Prince, Michael Roth, Michael Tamm and Daiana StolzEleni Papakonstantinou1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, SwitzerlandIoannis Klagas2Departement of Pharmacology, School of Medicine A.U.T.H, Thessaloniki, GreeceGeorge Karakiulakis2Departement of Pharmacology, School of Medicine A.U.T.H, Thessaloniki, GreeceSpasenija Savic Prince3Department of Pathology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Base, Basel, Switzerland
- Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Qingzhu Sun, Michael Tamm, Christopher Lambers and Michael RothKatrin Hostettler1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceQingzhu Sun1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandChristopher Lambers3Department of Thoracic Surgery, Medical University Vienna, Vienna, AustriaMichael Roth1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Michael Tamm, Christopher Lambers, Didier Lardinois and Michael RothKatrin Hostettler1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Tamm1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandChristopher Lambers3Department of Thoracic Surgery, Medical University Vienna, Vienna, AustriaDidier Lardinois4Division of Thoracic Surgery, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPDBy Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, George Karakiulakis, Michael Roth, Michael Tamm and Daiana StolzEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandIoannis Klagas2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceGeorge Karakiulakis2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacityBy Jyotshna Mandal, Michael Roth, Eleni Papakonstantinou, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte and Daiana StolzJyotshna Mandal1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital Basel, Basel, SwitzerlandRenaud Louis2Pneumology, University of Liege, Liege, BelgiumBranislava Milencovic3Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma4Pneumology, Medisch Centrum, Alkmaar, NetherlandsKonstantinos Kostikas5Pneumology, Medical School, University of Thessaly, Larisa, GreeceFrancesco Blasi6Pneumology, IRCCS Policlinico Milan, Milan, ItalyJoachim Aerts7Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital Maastricht, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson scoreBy Eleni Papakonstantinou, Ioannis Bonovolias, Michael Roth, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Ioachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte and Daiana StolzEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandIoannis Bonovolias2Lab of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital Basel, Basel, SwitzerlandRenaud Louis3Pneumology, University of Liege, Liege, BelgiumBranislava Milencovic4Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma5Pneumology, Medisch Center, Alkmaar, NetherlandsKonstantinos Kostikas6Pneumology, Medical School, University of Thessaly, Larisa, GreeceFrancesco Blasi7Pneumology, IRCCS Policlinico, Milan, ItalyIoachim Aerts8Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde9Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma10Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte12Pneumology, Medizinische Hochschule, Hannover, GermanyDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosisBy Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Chistopher Lambers, Michael Tamm and Michael RothKatrin Hostettler1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Klagas2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Bonovolias2Laboratories of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceChistopher Lambers3Department of Thoracic Surgery, Medical University Vienna, Vienna, AustriaMichael Tamm1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, SwitzerlandMichael Roth1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
- Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPDBy Jyotshna Mandal, Michael Roth, Luigi Costa, Lucas Boeck, Eleni Papakonstantinou, Michael Tamm and Daiana StolzJyotshna Mandal1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandLuigi Costa1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou2Pneumology, University Thessaly Medical School, Larissa, GreeceMichael Tamm1Clinic of Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pneumology, University Hospital Basel, Basel, Switzerland
- Anti-infectives and the Lung
Edited by Stefano Aliberti, James D. Chalmers and Mathias W. PletzBook | Published in 2017DOI: 10.1183/2312508X.erm7517ISBN (electronic): 978-1-84984-084-2Stefano AlibertiJames D. Chalmers - FigureĀ 1.
By Eleni Papakonstantinou and Daiana StolzBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Eleni PapakonstantinouDaiana Stolz
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
